Just diagnosed with Hereditary spastic paraplegia?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Hereditary spastic paraplegia, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Hereditary spastic paraplegia hub →Overview
Hereditary spastic paraplegia is a rare condition. Also known as Hereditary spastic paraparesis, SPG, Strümpell-Lorrain disease, Familial spastic paraplegia, HSP. Tomeko brings together the specialists, research, clinical trials, treatments and community for Hereditary spastic paraplegia so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:685 · ICD-10 G11.4 · GARD 0006637
Find care for Hereditary spastic paraplegia
Authoritative references for Hereditary spastic paraplegia
Research & market landscape for Hereditary spastic paraplegia
Following Hereditary spastic paraplegia for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Hereditary spastic paraplegia — the real-world landscape behind the condition, in one place.
- Latest Hereditary spastic paraplegia research on PubMed ↗
- Recruiting Hereditary spastic paraplegia trials on ClinicalTrials.gov ↗
- Explore the Hereditary spastic paraplegia research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Hereditary spastic paraplegia and every rare condition. See how Tomeko works with industry →
Common questions
What is Hereditary spastic paraplegia?
Hereditary spastic paraplegia is a rare condition. Also known as Hereditary spastic paraparesis, SPG, Strümpell-Lorrain disease, Familial spastic paraplegia, HSP. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Hereditary spastic paraplegia together in one place.
What are the symptoms of Hereditary spastic paraplegia?
Symptoms of Hereditary spastic paraplegia vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Hereditary spastic paraplegia.
How is Hereditary spastic paraplegia treated?
Treatment for Hereditary spastic paraplegia depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Hereditary spastic paraplegia, and review current options with them.
What causes Hereditary spastic paraplegia — is it genetic?
The cause and inheritance of Hereditary spastic paraplegia are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Hereditary spastic paraplegia can explain what it means for you and your family.
I was just diagnosed with Hereditary spastic paraplegia — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Hereditary spastic paraplegia, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Hereditary spastic paraplegia?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Hereditary spastic paraplegia, filtered to your area.
Are there clinical trials for Hereditary spastic paraplegia?
Tomeko shows live, recruiting studies for Hereditary spastic paraplegia from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion
